A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs
nytimes.com
31.08.2026 11:03
67 views
Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices over the past two decades.
Related stories
From Gianni Infantino to my dishwasher: Edith Pritchett’s week in Venn diagrams – cartoon
theguardian.com · 02.11
Most Israelis think settlements policy should change to avoid more sanctions, poll finds
theguardian.com · 02.11
Canada, coffins and confessionals
politico.eu · 02.11
Radical-right youth groups are at the root of Europe’s populist surge | Cas Mudde and Duncan McDonnell
theguardian.com · 02.11
Trump Makes Final Midterm Rally Push as Democrats Rise in Polls
newsweek.com · 02.11
Alaska Native Villages Face Election Without Promised Voting Sites
newsweek.com · 02.11